NO20071143L - Rekombinante vaksiner mot caligid copepoder (sjolus) og antigene sekvenser av disse - Google Patents

Rekombinante vaksiner mot caligid copepoder (sjolus) og antigene sekvenser av disse

Info

Publication number
NO20071143L
NO20071143L NO20071143A NO20071143A NO20071143L NO 20071143 L NO20071143 L NO 20071143L NO 20071143 A NO20071143 A NO 20071143A NO 20071143 A NO20071143 A NO 20071143A NO 20071143 L NO20071143 L NO 20071143L
Authority
NO
Norway
Prior art keywords
sjolus
vaccines against
recombinant vaccines
antigenic sequences
caligid copepods
Prior art date
Application number
NO20071143A
Other languages
English (en)
Other versions
NO342565B1 (no
Inventor
Neil W Ross
Stewart C Johnson
Mark D Fast
Kathryn Vanya Ewart
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Publication of NO20071143L publication Critical patent/NO20071143L/no
Publication of NO342565B1 publication Critical patent/NO342565B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Insects & Arthropods (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Molekylære mål og vaksiner mot dem i behandling av fiskelus er skaffet til veie, særlig caligid kopepoder. Vaksiner målrettet mot L. salmonis trypsin er vist å redusere mengden av fiskelus som er til stede i immunutfordret laks fiia dag 14 p. i. og fremover. Ytterligere og nye molekylære mål for vaksiner blir også skaffet til veie.
NO20071143A 2004-07-28 2007-02-28 Rekombinante vaksiner mot caligid copepoder (sjølus) og antigene sekvenser av disse. NO342565B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59162604P 2004-07-28 2004-07-28
PCT/CA2005/001178 WO2006010265A1 (en) 2004-07-28 2005-07-28 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof

Publications (2)

Publication Number Publication Date
NO20071143L true NO20071143L (no) 2007-02-28
NO342565B1 NO342565B1 (no) 2018-06-18

Family

ID=35785878

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071143A NO342565B1 (no) 2004-07-28 2007-02-28 Rekombinante vaksiner mot caligid copepoder (sjølus) og antigene sekvenser av disse.

Country Status (10)

Country Link
US (1) US8207132B2 (no)
EP (8) EP2397553B1 (no)
CA (1) CA2575218C (no)
CL (1) CL2011002334A1 (no)
DK (2) DK2397553T3 (no)
ES (2) ES2575156T3 (no)
NO (1) NO342565B1 (no)
PL (1) PL2397553T3 (no)
PT (1) PT2397553E (no)
WO (1) WO2006010265A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200801034A (en) * 2005-10-05 2008-01-01 Intervet Int Bv Novel sea lice vaccine
WO2007146359A2 (en) * 2006-06-14 2007-12-21 Diversa Corporation Sea lice antigen vaccines
CU23634A1 (es) 2007-05-31 2011-02-24 Ct Ingenieria Genetica Biotech Secuencias de ácido nucleico y aminoácidos, y vacuna para el control de infestaciones por ectoparásitos en peces
EP2211900A1 (en) 2007-11-19 2010-08-04 Calanus AS Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites
WO2013171548A2 (es) * 2012-05-17 2013-11-21 Tecnovax Chile S.A. Peptidos que inducen en peces una respuesta inmune contra copepodos y/o un escudo mucoso, vacunas, usos y métodos para modular la respuesta inmune de un pez y/o inducir la generación de un escudo mucoso
NO343723B1 (en) * 2016-06-10 2019-05-20 Aqua Health As Peptides for the inhibition of trypsin and sea lice infestation.
NO343281B1 (en) * 2016-12-30 2019-01-14 Aqua Health As Peptides for the inhibition of trypsin and sea lice infestation.
WO2017213521A1 (en) * 2016-06-10 2017-12-14 Aqua Health As Peptides for the inhibition of trypsin
WO2019145730A1 (en) 2018-01-25 2019-08-01 Benchmark Animal Health Limited Sea lice antigens and vaccines
GB201902425D0 (en) 2019-02-22 2019-04-10 Benchmark Animal Health Ltd Sea lice antigens and vaccines
WO2020161450A1 (en) * 2019-02-04 2020-08-13 Benchmark Animal Health Limited Sea lice vaccines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003953A1 (en) * 1986-11-24 1988-06-02 Genex Corporation Bioadhesives
EP0725838A4 (en) 1993-10-26 1997-02-26 United Biomedical Inc STRUCTURED SYNTHETIC ANTIGAN BANKS AS DIAGNOSTICS, VACCINE AND THERAPEUTIC AGENTS
JPH07163361A (ja) * 1993-12-14 1995-06-27 Kaiyo Bio Technol Kenkyusho:Kk ムラサキイガイ接着蛋白質遺伝子
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
US20020013955A1 (en) * 1998-06-10 2002-01-31 Sharon Ogden Production of recombinant protein in transgenic fish
AU2003229199A1 (en) 2002-05-31 2003-12-19 Alpharma As Liposome vaccine formulations for fin-fish
GB0513484D0 (en) 2005-07-01 2005-08-10 Accentus Plc Producing liquid hydrocarbons
TW200801034A (en) * 2005-10-05 2008-01-01 Intervet Int Bv Novel sea lice vaccine

Also Published As

Publication number Publication date
DK2405003T3 (en) 2015-09-21
EP2405004A1 (en) 2012-01-11
US20080003233A1 (en) 2008-01-03
DK2397553T3 (en) 2016-06-13
CA2575218C (en) 2013-07-09
CL2011002334A1 (es) 2012-03-30
PL2397553T3 (pl) 2017-03-31
EP2402445A1 (en) 2012-01-04
ES2575156T3 (es) 2016-06-24
EP2397553A1 (en) 2011-12-21
WO2006010265A1 (en) 2006-02-02
EP1789554B1 (en) 2018-07-04
NO342565B1 (no) 2018-06-18
EP1789554A1 (en) 2007-05-30
EP2407542A1 (en) 2012-01-18
PT2397553E (pt) 2016-06-08
CA2575218A1 (en) 2006-02-02
EP2397552A1 (en) 2011-12-21
EP1789554A4 (en) 2009-05-06
EP2405003A1 (en) 2012-01-11
US8207132B2 (en) 2012-06-26
EP2405003B1 (en) 2015-09-02
ES2548677T3 (es) 2015-10-20
EP2397553B1 (en) 2016-05-04
EP2410055A1 (en) 2012-01-25

Similar Documents

Publication Publication Date Title
NO20071143L (no) Rekombinante vaksiner mot caligid copepoder (sjolus) og antigene sekvenser av disse
NO20060416L (no) Ny anvendelse I
BR0316758A (pt) Vacinas baseadas em levedura como imunoterapia
WO2004069190A3 (en) Combination therapy for treating protein deficiency disorders
MX2008013993A (es) Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
DK1187629T3 (da) Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
EA200800415A1 (ru) Удаление пероксида из носителя для доставки лекарственного средства
NO20031646L (no) Adjuvanssammensetning omfattende et immunostimulatorisk oligonukleotid og en tokol
WO2012003474A3 (en) Compositions and methods related to protein a (spa) variants
WO2008108910A3 (en) Negative genetic regulation of cancer cell renewal in synergy with notch- or numb-specific immunotherapy
SG146643A1 (en) Treating or preventing restless legs syndrome using prodrugs of gaba analogs
EA201071133A1 (ru) Композиция для укладки волос
AR026059A1 (es) Virus de plantas modificadas y metodos para su uso
NO20070854L (no) Humane monoklonale antistoffer mot humant IL-4.
UA89800C2 (en) Acylated nonadepsipeptides used as lysobactin derivatives
DK1482795T3 (da) Nye immuneffektor-forbindelser
WO2007097789A8 (en) Attenuated francisella and methods of use
DE60320800D1 (de) Verwendung von saatmehl als bodenpestizid
DE602004019288D1 (de) Schnellösliches azithromycin in einzeldosisform
WO2005123112A3 (en) Method of enhancing the immune response to a vaccine
WO2002058535A3 (en) Use of combretastatin a4 and its prodrugs as an immune enhancing therapy
WO2005046571A3 (en) Lactoferrin as an adjuvant in cancer vaccines
MXPA04007491A (es) Tratamiento profilactico y terapeutico de infecciones y otras enfermedades con compuestos inmunoefectores.
MY127452A (en) Vaccines.
MXPA05008131A (es) Metodos para la modulacion de una respuesta inflamatoria.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees